Big Pharma

The World's Biggest Players in Pharma

Pfizer once again tops Pharmaceutical Executive's latest annual ranking of the top 50 biopharma companies for prescription drug sales. Of Rx revenues of $72 billion in 2021, more than half were generated by the company's Covid-19 vaccine, Comirnaty. Pfizer also had the highest R&D spend in the ranking at almost $14 billion.

The company had led the ranking between 2015 and 2019, but was overtaken by Swiss company Roche in 2020 beause of its significant presence in Covid testing analytics. The fastest riser in the top 10 of Rx sales and in regards to market cap, Illinois-based AbbVie, did not sell COVID-19 related products, however. Its monoclonal antibody drug Humira, which is used to treat conditions like arthritis, Crohn's disease and psoriasis, was the highest-grossing non-vaccine Rx drug of 2021.

According to the publication, Pfizer could eclipe Humira sales in 2022, however, with its Covid treatment, Paxlovid.

Description

This graphic shows the top ten biopharma companies ranked by prescription drug sales and expenditure on research and development in 2021.

Download Chart
Projected top pharmaceutical companies based on new sales 2023
Premium statistics
Leading European pharmaceutical companies by Rx sales 2023
Projected top pharmaceutical companies based on sales 2023
Premium statistics
Top 50 pharmaceutical companies - Rx sales and R&D spending 2023
Premium statistics
2024 list of global top 10 biotech and pharmaceutical companies based on revenue
Top pharmaceutical companies in Sweden by sales 2022

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!

Do you still have questions?

Feel free to contact us anytime using our contact form or visit our FAQ page.

Statista Content & Design

Need infographics, animated videos, presentations, data research or social media charts?

More Information